5 completed, 2 terminated, 2 withdrawn, 1 unknown. 2 Not applicable, 2 Phase 3, 2 Phase 4, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
| Phase 3 | 2 | Withdrawn 2 |
| Phase 4 | 2 | Terminated 2 |
| Phase 1 | 1 | Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow naratriptan: new trials by email Literature Review of naratriptan trials Research Report on naratriptan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Status Migrainosus - Differentiating Between Responders and Non-responders Bupivacaine, Naratriptan Pill, Dexamethasone - Migraine | Phase 1 / Phase 2 | Unknown | Hartford HealthCare | 50 | 2016-11-30 | 2018-08-31 |
| Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine. naratriptan + naproxen, naratriptan, naproxen - Migraine, Headache | Phase 3 | Withdrawn | Ache Laboratorios Farmaceuticos S.A. | 2014-07-01 | 2016-03-16 | |
| Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine Fixed-dose combination of naratriptan+naproxen, Naratriptan, Naproxen - Migraine, Headache | Phase 3 | Withdrawn | Ache Laboratorios Farmaceuticos S.A. | 2011-12-01 | 2016-10-19 | |
| Special Drug Use Investigation for AMERGE® Tablet (Long-term) Naratriptan - Migraine Disorders | Completed | GlaxoSmithKline | 300 | 2009-05-01 | 2015-08-13 | |
| Drug Use Investigation for AMERGE (Naratriptan Hydrochloride) Tablet Naratriptan - Migraine Disorders | Completed | GlaxoSmithKline | 500 | 2009-04-01 | 2013-05-20 | |
| Bioequivalency Study of Naratriptan Hydrochloride 2.5 mg Under Fasted Conditions naratriptan hydrochloride - Migraine | Not applicable | Completed | Roxane Laboratories | 35 | 2007-09-01 | 2018-01-23 |
| Bioequivalency Study of Naratriptan Hydrochloride 2.5 mg Under Fed Conditions naratriptan hydrochoride - Migraine | Not applicable | Completed | Roxane Laboratories | 33 | 2007-08-01 | 2018-01-23 |
| Efficacy of a Triptan in the Treatment of Hostility and Aggression Among Convicts With a Psychiatric Treatment Order naratriptan, placebo - Psychotic Disorders, Antisocial Personality Disorder | Phase 4 | Terminated | UMC Utrecht | 8 | 2006-11-01 | 2015-01-26 |
| Naratriptan for the Treatment of Post Traumatic Headache Associated With Cognitive Dysfunction naratriptan HCl - Post Traumatic Headache | Phase 4 | Terminated | Cady, Roger, M.D. | 12 | 2006-10-01 | 2013-02-11 |
| Sumatriptan and Naratriptan Pregnancy Registry Sumatriptan, Naratriptan, Sumatriptan-naproxen combination - Migraine Disorders | Completed | GlaxoSmithKline | 868 | 2001-12-01 | 2014-11-03 |
Migraine Disorders (8) · Headache (3) · Antisocial Personality Disorder (1) · Craniocerebral Trauma (1) · Disruptive, Impulse Control, and Conduct Disorders (1) · Post-Traumatic Headache (1) · Psychotic Disorders (1)
GlaxoSmithKline (3) · Ache Laboratorios Farmaceuticos S.A. (2) · Roxane Laboratories (2) · Cady, Roger, M.D. (1) · Hartford HealthCare (1) · UMC Utrecht (1)
United States (4) · Netherlands (1)
Linda Bavisotto, M.D. (2) · Adriano van der Loo, MD (1) · Berend Olivier, PhD (1) · Brian Grosberg, MD (1) · Deusvenir S Carvalho (1) · Frank Koerselman, MD, PhD (1) · Henk Nijman, PhD (1) · Rob L. van Ojen, MD, PhD (1) · Roger K Cady, MD (1)